Day: September 19, 2024

DMG Blockchain Solutions Announces Issuance of U.S Patent for Custom Mempool Protocol, Participation at Upcoming Investor Conference

Written by Customer Service on September 19, 2024. Posted in Public Companies.

VANCOUVER, British Columbia, Sept. 19, 2024 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) (“DMG”), a leading vertically integrated blockchain and data center technology company, announces the issuance of U.S. Patent No. 11,810,103 by the U.S. Patent and Trademark Office (USPTO). The patent covers DMG’s innovative Custom Mempool Protocol for processing cryptographic events. This patented system allows applications to send events to hashing processors that operate on a custom mempool protocol, separate from the public blockchain protocol. Events are hashed only with other events that meet specific screening criteria, preventing transactions from being propagated to external nodes. This system enhances control over which events are processed, improving security...

Metagenomi to Present at Chardan’s 8th Annual Genetic Medicines Conference

Written by Customer Service on September 19, 2024. Posted in Public Companies.

EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced that company management will participate in the following events at Chardan’s 8th Annual Genetic Medicines Conference:Fireside chat on Monday, September 30, 2024, 2:30 PM – 3:00 PM ET with Brian Thomas, CEO and Founder, Dr. Sarah Noonberg, CMO, and Alan Brooks, SVP Preclinical. Panel discussion titled, “Genome editing for gene insertion and gene correction – where we are and what’s next,” on Monday, September 30, 2024, 5:00 PM – 5:30 PM ET with Brian C. Thomas, CEO and Founder.A live conference webcast of the fireside chat will be available in the investor...

Kineta, Inc Transitioning from Nasdaq to OTC Markets

Written by Customer Service on September 19, 2024. Posted in Public Companies.

Kineta will be trading under the symbol “KANT” on OTC Pink Kineta will continue to pursue strategic alternatives as previously announced TuHURA Biosciences has an exclusivity right and a right of first offer for Kineta’s KVA12123 program The ongoing KVA12123 Phase 1 study is open for new patient enrollment and following those patients previously enrolled. SEATTLE, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kineta, Inc., a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that it has transitioned from Nasdaq to the OTC Market. Kineta stock now trades under the ticker symbol “KANT” on the OTC Pink Open Market platform operated by OTC Markets Group Inc. Kineta remains committed to maintaining the highest standards of corporate governance...

Astrotech Reports Fiscal Year 2024 Financial Results

Written by Customer Service on September 19, 2024. Posted in Earnings Releases And Operating Results.

AUSTIN, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial results for the fiscal year ended June 30, 2024. Financial Highlights & Fiscal Year Developments Revenue increased to $1.7 million as Astrotech’s subsidiary, 1st Detect, gained traction in the international passenger market with its explosives trace detectors (“ETD”). Gross margin increased to 45% for the year compared to 41% in the prior period, due to a higher proportion of recurring revenue. The U.S. Transportation Security Administration (“TSA”) approved the TRACER 1000 for the Air Cargo Security Technology List, which permits air cargo companies in the United States to use our equipment in their operations. This action advances the TRACER 1000 to Stage II testing and allows us to...

Cayson Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering

Written by Customer Service on September 19, 2024. Posted in Public Companies.

NEW YORK, Sept. 19, 2024 (GLOBE NEWSWIRE) — Cayson Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The Company’s units will be listed on the Nasdaq Global Market (“Nasdaq”) and will begin trading tomorrow, September 20, 2024, under the ticker symbol “CAPNU.” Each unit consists of one ordinary share and one right entitling its holder to receive one tenth of one ordinary share upon the Company’s completion of an initial business combination, subject to adjustment. Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on Nasdaq under the symbols “CAPN” and “CAPNR,” respectively. The Company is a Cayman exempt company, formed as a blank check company for the purpose of entering into...

Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital

Written by Customer Service on September 19, 2024. Posted in Mergers And Acquisitions.

SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC (“Concentra”) to acquire all of the Company’s outstanding shares of common stock for $12.00 per share in cash. As alternative consideration, Concentra stated that it would consider, assuming it receives sufficient interest from existing stockholders, inviting interested stockholders to elect to continue to participate in any future value realized from the Company’s ongoing business by receiving a contingent value right in lieu of receiving $12.00 per share in cash. According to a Schedule 13D filed...

Amaya Big Sky Capital Announces Letter of intent with Flight Food & Beverage Partners for Proposed Qualifying Transaction

Written by Customer Service on September 19, 2024. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES ‎‎ Vancouver, BC, Sept. 19, 2024 (GLOBE NEWSWIRE) — Amaya Big Sky Capital Corp. (“Amaya” or the “Company”) (TSX-V: AMYA.P), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “TSX-V”), is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) with Flight Food & Beverage Partners Inc. (“Flight”), an arm’s length party, dated September 17, 2024, in respect of a proposed reverse takeover transaction (the “Transaction”) intended to constitute Amaya’s “qualifying transaction”, as defined under Policy 2.4 of the TSX-V. Upon completion of the Transaction, subject to receipt of all requisite approvals, it is anticipated that the Resulting Issuer (as defined below) will be listed...

Diamondback Energy Announces Launch of Secondary Common Stock Offering

Written by Customer Service on September 19, 2024. Posted in Public Companies.

MIDLAND, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”) announced today the launch of an underwritten public offering of 11,270,000 shares of its common stock by certain Legacy Endeavor Stockholders (the “Selling Stockholders”), subject to market and other conditions (the “Secondary Offering”). Diamondback will not receive any proceeds from the sale of the shares by the Selling Stockholders. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 1,390,500 shares of common stock. In addition, Diamondback has authorized the purchase from the underwriters of 2,000,000 shares of common stock offered in the Secondary Offering (the “Share Repurchase”). The Share Repurchase is part of the Diamondback’s existing share repurchase program....

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.24 Per Share for Q3 2024

Written by Customer Service on September 19, 2024. Posted in Dividend Reports And Estimates.

HOUSTON, Sept. 19, 2024 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a quarterly distribution of $0.24 per share for the fiscal quarter ended August 31, 2024. This distribution, which is an increase of $0.02 per share over the prior quarter’s distribution, is payable to common stockholders on October 7, 2024 (as outlined in the table below). “We are pleased with KYN’s performance thus far in fiscal 2024 and we are excited to announce this 9% increase to the Company’s distribution,” stated Jim Baker, KYN’s Chairman, President and CEO. “We understand how important distributions are to the Company’s investors, and our goal is to steadily increase KYN’s distribution over time as supported by the Company’s operating results,” continued Mr. Baker.Record Date / Ex-Date Payment Date Distribution...

Battalion Oil Corporation Announces Amendment to Merger Agreement with Fury Resources, Inc.

Written by Customer Service on September 19, 2024. Posted in Mergers And Acquisitions.

Houston, Texas, Sept. 19, 2024 (GLOBE NEWSWIRE) — Battalion Oil Corporation (NYSE American: BATL) (“Battalion” or the “Company”) announced today that it has entered into an amendment to the previously disclosed Agreement and Plan of Merger (as amended, the “Merger Agreement”) with Fury Resources, Inc. (“Buyer” or “Parent”), pursuant to which Parent has agreed to acquire all of the outstanding shares of Common Stock of the Company (the “Common Stock”) for $7.00 per share in cash, without interest (the “Merger Consideration”). The holders of all of the outstanding shares of the Preferred Stock of the Company, Luminus Management, LLC (“Luminus”), Gen IV Investment Opportunities, LLC, and funds and accounts managed by Oaktree Capital Management, L.P. (“Oaktree”), or their respective affiliates (collectively, the “Rollover Stockholders”),...

Day: September 19, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice